US Appeals Court Backs Dismissal Of Bystolic ‘Pay-For-Delay’ Case

The US Court of Appeals for the Second Circuit afirmed a US district court decision to dismiss purchaser and payer claims linked to so-called “pay-for-delay” agreements with generics firms over nebivolol rivals to Bystolic.

Appeal_Gavel
The US Court of Appeals for the Second Circuit backed the district court’s dismissal. • Source: Shutterstock

A US district court decision that rejected complaints over reverse-payment deals involving Forest Laboratories and multiple generics firms around Bystolic (nebivolol) was upheld by an appeals court.

Key Takeaways

  • A US appeals court upheld a district court decision dismissing a pay-for-delay case involving Forest Labs and other generics firms.

Purchaser and payer plaintiffs in the litigation over the so-called “pay-for-delay” deals, including CVS Caremark and Rite Aid, had “fail[ed]...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics